Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Receives $5.5M from Stock Sale

NEW YORK, May 4 (GenomeWeb News) - Tripos said today that Boston-based Midwood Capital has purchased 1.8 million shares of its convertible preferred stock, representing about 18 percent of the company's stock on an as-converted basis, for about $5.5 million.

 

Midwood bought the stock at $3 per share, and also received 550,000 five-year common stock warrants that can be exercised at $3.50, the statement said.

 

The company's shares closed at $2.91 yesterday.

 

Tripos' convertible preferred stock bears a dividend at an annual rate of 10.5 percent and is redeemable in two years, the company said.

 

Seven Hills Partners acted as the placement agent for the transaction. Tripos retained the financial advisory firm in January.

 

Tripos said it is continuing to work with Seven Hills to enhance the growth of its research and informatics businesses.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.